Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $1.3.

  • Innoviva's EPS (Basic) rose 640000.0% to $1.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.59, marking a year-over-year increase of 2137.4%. This contributed to the annual value of $0.37 for FY2024, which is 8654.55% down from last year.
  • As of Q3 2025, Innoviva's EPS (Basic) stood at $1.3, which was up 640000.0% from $1.01 recorded in Q2 2025.
  • Innoviva's EPS (Basic)'s 5-year high stood at $3.81 during Q3 2022, with a 5-year trough of -$0.74 in Q1 2025.
  • For the 5-year period, Innoviva's EPS (Basic) averaged around $0.7, with its median value being $0.58 (2024).
  • As far as peak fluctuations go, Innoviva's EPS (Basic) plummeted by 285000.0% in 2024, and later soared by 640000.0% in 2025.
  • Innoviva's EPS (Basic) (Quarter) stood at $1.04 in 2021, then skyrocketed by 266.35% to $3.81 in 2022, then crashed by 66.93% to $1.26 in 2023, then plummeted by 98.41% to $0.02 in 2024, then surged by 6400.0% to $1.3 in 2025.
  • Its last three reported values are $1.3 in Q3 2025, $1.01 for Q2 2025, and -$0.74 during Q1 2025.